TAS-205 is a hematopoietic prostaglandin D synthase (HPGDS) inhibitor that selectively suppresses prostaglandin D2 (PGD2) synthesis in cellular enzymatic assays and in vivo models, effectively reducing eosinophil infiltration into the nasal cavity and late-phase nasal congestion; it exhibits significant synergistic inhibitory effects when combined with montelukast (HY-13315A), and shows moderate inhibitory effects on both early- and late-phase nasal congestion when co-administered with fexofenadine (HY-B0801A).